rTMS for Depression
Repetitive Transcranial Magnetic Stimulation is a leading non-invasive treatment for major depressive disorder, especially when antidepressants have not been enough. At Neuropulsas in Vilnius, we deliver a full accelerated course in a single week.
- FDA/CE-approved for major depressive disorder
- 30 sessions in 1 week (accelerated protocol)
- Reviewed by a psychiatrist and a neurologist
- €2,900 — treatment only
How it works
rTMS delivers brief magnetic pulses to the dorsolateral prefrontal cortex — a region under-active in depression — to restore healthy network activity. It is non-invasive and does not require anesthesia.
Who it suits
Adults with moderate to severe depression who want a drug-free option, or who have not fully responded to one or more antidepressants. We assess each patient carefully before recommending treatment.
Frequently asked questions
Is rTMS proven for depression?+
Yes. rTMS has been FDA-cleared for major depressive disorder since 2008 and is recommended in international treatment guidelines, particularly for patients who have not fully responded to antidepressants.
What is the success rate?+
In published trials, roughly 50–60% of patients respond to rTMS and around a third achieve remission. Our team will discuss realistic expectations during your consultation.
Can I stay on antidepressants?+
Usually yes. rTMS is often combined with existing medication, and changes are coordinated with your prescribing doctor.
How long does the benefit last?+
Many patients experience sustained improvement for 6–12 months after a full course. Maintenance sessions can be planned if needed.
Ready to take the next step?
We typically reply within one working day with availability and next steps.
Ask about depression treatment